A tsunami of regulations will require biopharma to look to the high ground of knowledgeable partners

Fierce Pharma June 3, 2024
Sponsored by: Cencora

Already weathering the complex biopharma landscape in the U.S. and in Europe, biopharma manufacturers can avoid drowning in the approaching implementation of sweeping regulations set to wash over the industry with regulatory consulting expertise that provides innovative solutions.

In addition to responding to technological changes and increased demand for drugmakers to become more patient-centric in their development, the biopharma industry is also coming under more regulatory pressure this year.

“Global manufacturers are under challenges on multiple fronts,” David Senior, Senior Vice President, Market Economics at Cencora (formerly AmerisourceBergen), said. “We are cognizant of the challenges and how the pressure could affect manufacturers in terms of net revenues and pricing strategies, so we are doing a lot of analysis...

Today's Sponsors

Today's Sponsor